SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-143616
Filing Date
2019-05-10
Accepted
2019-05-10 07:26:40
Documents
77
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d730852d10q.htm 10-Q 505100
2 EX-31.1 d730852dex311.htm EX-31.1 6919
3 EX-31.2 d730852dex312.htm EX-31.2 6928
4 EX-32.1 d730852dex321.htm EX-32.1 4910
  Complete submission text file 0001193125-19-143616.txt   5820112

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT orgo-20190331.xml EX-101.INS 1561371
6 XBRL TAXONOMY EXTENSION SCHEMA orgo-20190331.xsd EX-101.SCH 48650
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE orgo-20190331_cal.xml EX-101.CAL 50863
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE orgo-20190331_def.xml EX-101.DEF 265815
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE orgo-20190331_lab.xml EX-101.LAB 381249
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orgo-20190331_pre.xml EX-101.PRE 355052
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37906 | Film No.: 19812834
SIC: 2834 Pharmaceutical Preparations